Pharma Aids Limited (DSE:PHARMAID)
Bangladesh
· Delayed Price · Currency is BDT 518.30
+2.30 (0.45%)
At close: Dec 4, 2025
Pharma Aids Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 3, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Market Capitalization | 1,617 | 1,671 | 2,086 | 2,467 | 2,543 | 1,241 | Upgrade
|
| Market Cap Growth | -25.26% | -19.89% | -15.46% | -2.98% | 104.82% | -2.50% | Upgrade
|
| Enterprise Value | 1,598 | 1,651 | 2,039 | 2,459 | 2,502 | 1,228 | Upgrade
|
| Last Close Price | 518.30 | 535.50 | 665.66 | 786.35 | 805.39 | 389.43 | Upgrade
|
| PE Ratio | 23.99 | 26.18 | 34.09 | - | 73.14 | 24.70 | Upgrade
|
| PS Ratio | 3.57 | 3.81 | 4.95 | 8.00 | 7.87 | 4.43 | Upgrade
|
| PB Ratio | 3.57 | 3.86 | 6.08 | 8.66 | 8.25 | 4.27 | Upgrade
|
| P/TBV Ratio | 3.57 | 3.86 | 6.08 | 8.66 | 8.25 | 4.27 | Upgrade
|
| P/FCF Ratio | 189.14 | - | 92.27 | 487.65 | 87.25 | 58.77 | Upgrade
|
| P/OCF Ratio | 24.47 | 42.02 | 91.53 | 339.47 | 75.13 | 39.53 | Upgrade
|
| EV/Sales Ratio | 3.52 | 3.77 | 4.84 | 7.97 | 7.74 | 4.38 | Upgrade
|
| EV/EBITDA Ratio | 16.49 | 18.36 | 22.34 | 134.45 | 40.46 | 16.47 | Upgrade
|
| EV/EBIT Ratio | 17.79 | 19.79 | 24.18 | 230.56 | 46.32 | 18.52 | Upgrade
|
| EV/FCF Ratio | 186.94 | - | 90.23 | 485.99 | 85.84 | 58.15 | Upgrade
|
| Debt / Equity Ratio | 0.05 | 0.06 | 0.05 | 0.04 | 0.00 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 0.21 | 0.30 | 0.20 | 0.63 | 0.02 | 0.00 | Upgrade
|
| Debt / FCF Ratio | 2.43 | - | 0.80 | 2.27 | 0.03 | 0.01 | Upgrade
|
| Asset Turnover | 0.81 | 0.83 | 0.98 | 0.81 | 0.89 | 0.85 | Upgrade
|
| Inventory Turnover | 4.42 | 4.88 | 4.92 | 4.27 | 4.26 | 5.48 | Upgrade
|
| Quick Ratio | 1.42 | 1.33 | 1.36 | 1.77 | 2.50 | 3.47 | Upgrade
|
| Current Ratio | 3.03 | 3.33 | 3.06 | 3.26 | 4.32 | 5.17 | Upgrade
|
| Return on Equity (ROE) | 16.56% | 16.46% | 19.50% | -2.15% | 11.60% | 18.32% | Upgrade
|
| Return on Assets (ROA) | 10.04% | 9.83% | 12.24% | 1.75% | 9.35% | 12.60% | Upgrade
|
| Return on Capital (ROIC) | 13.14% | 12.71% | 16.04% | 2.20% | 11.24% | 14.97% | Upgrade
|
| Return on Capital Employed (ROCE) | 19.70% | 19.20% | 24.60% | 3.70% | 17.50% | 22.80% | Upgrade
|
| Earnings Yield | 4.17% | 3.82% | 2.93% | -0.26% | 1.37% | 4.05% | Upgrade
|
| FCF Yield | 0.53% | -1.04% | 1.08% | 0.21% | 1.15% | 1.70% | Upgrade
|
| Dividend Yield | 0.58% | 0.56% | 0.38% | 0.13% | 0.62% | 1.28% | Upgrade
|
| Payout Ratio | 11.37% | 12.01% | 7.90% | - | 72.69% | 29.94% | Upgrade
|
| Total Shareholder Return | 0.58% | 0.56% | 0.38% | 0.13% | 0.62% | 1.28% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.